This is an open label, cross-over group, single-centre randomised controlled trial comparing Medium Cut Off Dialyser with High Flux Dialyser in patients with end-stage renal disease on chronic haemodialysis.
This is an open label, cross-over group, single-centre randomised controlled trial comparing Medium Cut Off(MCO) Dialyser with High Flux Dialyser in patients with end-stage renal disease on chronic haemodialysis. Patients who are initially on High Flux Dialyser will be randomised into either MCO Dialyser (modality A) or High Flux Dialyser (modality B) dialysate. The dialysate flow (QD) and blood flow (QB) remains unchanged throughout study period. After 12 treatments (4 weeks) a 4-weeks wash-out phase using High-flux dialyzers was performed to minimize carry-over-effects. After the 4-weeks washout phase, the modality is switched to the alternative one for 8 weeks.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Enrollment
44
medium cut-off dialyser
high flux dialyser
Selayang Hospital
Batu Caves, Selangor, Malaysia
Removal of Beta-2-microglobulin
Changes to Beta-2-microglobulin level
Time frame: 4 weeks
Changes to Quality of Life
Changes to Quality of life Using SF-36
Time frame: 27 weeks
Inflammatory state after intervention
Changes to C-Reactive Protein Level
Time frame: 4 weeks
Changes to Quality of Life
Changes to Quality of life Using EQ-5D-5L
Time frame: 27 weeks
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.